Canada Markets closed

Titan Medical Inc. (TMD.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.67000.0000 (0.00%)
At close: 03:44PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • c
    carpe
    I don't think that TMDI has another 10% in gains in it. Looks pretty bad here. I actually found (http://Achieverspot.tech) the other day and their stocks are way better...
  • T
    The Stock Guru
    JAMES POUND SALT 🧂
  • R
    Ryan
    +15% and no comments! Wow. Bears have nothing to say now?
  • M
    Michael
    These jokers don’t deserve to be a 60 cent stock. Quite clear… but not only is benchmark delayed, they haven’t received all of the component parts yet from Titan. Go away to him at another nine months until the existing timeline
  • e
    earl
    MDT May possibly make an offer at 4 Dollars a share. I’ll take it . Anything beats watching this Sea of paint dry!!
  • M
    Michael
    How is the biggest #$%$ on the Nasdaq doing today? Not tanking 20% as usual - OMG times are a changing - SCOOOP!
  • J
    James
    up 15% Down 15% Somethings never change!
  • M
    Michael
    Say goodbye to your investment folks! Mr. Vance has quite a history with shareholders of the companies that he has run!
  • L
    Lam
    Is it today last day before get delist from Nasdaq (under $1 for 180 days from 12/30/2022 to 06/28/2022)?

    https://finance.yahoo.com/news/titan-medical
  • T
    The Stock Guru
    WRONG AGAIN LIVENDI!!!!
  • l
    livendi
    I keep saying that licensing deal ended up being a negative because we can’t relicense our best ip. Stock guru. Wrong again. This may become a buy if and when enos is ready for fda. God bless all
  • T
    Tom
    I invested in Titan Medical Inc years ago, and have done very well on paper.
    Although I get anxious when the stock price drops, I shake it off and realize that eventually the stock price will sky rocket when they either get bought out or their product enters the market place.
    If anyone lives near the corporate office in Toronto, or their office in Chapel Hill, and has experience in hardware and software engineering, you may want to see the positions posted earlier this month on their website, then apply for one of the positions.
    While you’re there ask when they will need to hire sales people to promote the Enos surgical system, report back to us so we can load up on more shares.
    As for Shorters and Bashers, they only get interested in companies that have great potential for success.
    Ignore them, mute them, buy on the dips, and hold tight to every share of stock you own.
    RELAX!!
    You patience will be greatly rewarded.
    Go TMDI!
  • R
    Ryan
    In case anyone missed the news this morning. TMDI completes pre-clinical studies and is ready to move into the final phase of product development before applying for IDE (investigational device exemption) with FDA.

    TORONTO, October 25, 2021--(BUSINESS WIRE)--Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed its scheduled pre-clinical studies with its Enos™ robotic single access surgical system, performed in accordance with FDA’s good laboratory practice (GLP) regulations. GLP is a set of principles intended to assure the quality and integrity of non-clinical laboratory studies that are intended to support marketing permits for products regulated by government agencies.
  • L
    Larry
    I have never before posted a comment here. As an investor since. 2014, I believe that the principle and improvements with TMDI SPORT system is a vast improvement over the DaVinci system. I feel that from a business standpoint, Hospital systems will be financially ready to replace a 10 year old system as well. If you followed DaVinci stock in the 2 years prior to coming to market, it went from under $2/share to over $500/share. Unfortunately we have been significantly diluted by multiple stock releases and the warrants issued to raise funds for continued development.
    Medtronic investment in TMDI a is very meaningful and provides needed funds and more importantly, credibility to TMDI. They may choose to buy the company, and it will be in the Billion range! That will depend on the approvals to be able to market the product. I maintain positive thoughts! Larry E, MD
  • J
    Justjohn
    My thoughts on Titan and Robotically Assisted surgery.. Please excuse any typos and misspellings. The print is small, and I cannot see as well as I use to.

    In 2000 I started investing in Computer Motion. As a graduation present, I bought my daughter 200 shares at $10. When the stock dropped to $8, I bought a 1000 shares for myself. When the price dropped to $4, I bought 4000 shares. When it dropped to $2, I bought 4000 shares. When it dropped to $2, I doubled up. I bought my last 5000 at $1. Before I ran out of cash I had 26000 shares of computer motion.

    As I was accumulation Computer Motion, Computer Motion and Intuitive Surgical were suing each other over patent infringements. I obtained summaries of the lawsuits. Though I am not a lawyer, I could understand them. I thought Computer Motion had the best case.

    In 2003, before the case was settled in Court, Computer Motion was merged into Intuitive Surgical. When the dust settled I ended up with 6800 shares of Intuitive Surgical, at twice what I paid for them. The owners of Computer Motion ended up getting 1/3 of the Intuitive Surgical stock.

    If I held those shares today, I would have 20,400 share at $790 a share, living on my private island in the Caribbean. However, I sold my last 2200 shares for $510. So I am stuck in cold freezing Syracuse, NY.

    I spent most of my working years as hardware/software engineer supporting Medical Researchers. So I somewhat understand Robot assisted surgery.

    Because I think Intuitive Surgical share price is frothy and maybe always has been because the have always been the only game in town.

    I believe there are better methods to treat some of the illnesses Intuitive Surgical treats. For example, I strongly believe precision radiation surgery is better for most Protate cancers than surgery, minimal or otherwise, with fewer side effects. There are studies that say so and at less than 1/2 the cost.

    However, that does not mean that surgery is obsolete. In general minimally invasive is usually than open surgery.

    I believe the Intuitive Surgical share price is frothy, and overpriced and overkill for many procedures performed on the Da Vinci.

    Because of this, I have sought and researched other companies developing soft tissue robotically assisted surgery's. To date the only company that comes close to efficiently competing with Intuitive Surgical is Titan Medical or Medtronic's if they acquire Titan Medical.
  • B
    Barry
    08:00 AM EST, 12/30/2020 (MT Newswires) -- Medical device company Titan Medical (TMD.TO)t has received a written response from the U.S. FDA to its Request for Information regarding the regulatory requirements applicable to its robotically assisted surgical device (RASD), the Enos Robotic Single Access System. The FDA has indicated that, based on information to hand, the Enos system is appropriate for classification through the De Novo pathway.

    The company says it will likely proceed with a De Novo classification request for its Enos system in place of a 510(k) submission. Should the FDA grant the De Novo classification request, the Class II device would be cleared to be marketed. In addition, a new classification regulation will be established, and the new device may then serve as a predicate device for 510(k) submissions of future devices of the same type.

    (The de novo pathway for device marketing rights was added to address novel devices of low to moderate risk that do not have a valid predicate device. A predicate device is cleared to be marketed in the US and may also be used as a comparison for new medical devices.)
  • T
    Tom
    James is a paid basher. Mute him. I do it often on sites other than this one.
    Go TMDI!
  • K
    Kevin
    The fact that this robot is technically less invasive as it only requires a single incision as opposed to several with other multi-port robots AND it can be used in more efficient, less costly ambulatory surgery centers is a game changer. For reference, the same GYN procedure performed in the hospital is often 4 times the cost of the same procedure done in an ambulatory surgery center. If a patient has a high deductible health plan, where do you think they'd prefer to have the procedure done?? The market is going to continue to drive appropriate care to ambulatory surgery centers and other outpatient settings. I hope the Titan marketing and sales team is ready for the challenge. It will take a minor miracle to compete with the salesforce of Intuitive, but sometimes the products just sell themselves because they simply make more sense. I really hope that is the case here.
  • J
    JL Prestige
    @Kevin spot on my friend... To add onto your point... Intuitive's only product is the Da Vinci robot.... they are the laparoscopic robot pioneers and only current option.... that being said, they leverage the MD's to push hard against hospital admin to make huge capital purchases... They do this without being willing/able to offset with other products, and they do not negotiate since they are the only players..... When MDT disrupts this space, look for them to do major finance deals leveraging disposable business in OBGYN, Urology to offset initial capital outlay upfront.... Also, GPO contracting will play a role as competition is essential... Bottom line is, MDT is a much larger company with greater bandwidth to steal share from Intuitive.... Lastly, the rebranding of ENOS single port with focus on OBGYN and Urology is key as the pelvic area is very tight quarters and a lot of MD's are not thrilled with the single port that was developed by ISRG, and MDT already has a lot of presence in OBGYN and Urology space.... The stars are all aligning
  • J
    JL Prestige
    REPOST....Extremely bullish!!!

    Geoffrey Martha MDT CEO
    "Look, the M&A, I'll call them bite size, but smaller tuck-in deals, where we're getting at these companies at relatively early stage, in most cases BEFORE COMMERCIALIZATION. It seems to be something that's working for us. So, we can do more of these. We add more value and we're getting them at values that make sense. So, we're getting good returns on these. And we're spreading our risk across a number of these deals. And I would expect that to continue. And I think the most of the work of these tuck-ins, most of the volume rather, will come around our existing therapies and existing markets to augment them. And really, I look at it as an extension of our organic growth strategy because we're not buying growth here. We're BUYING TECHNOLOGY. And then, kind of adding to that, whether it be additional technology or clinical science, and then making these standard of care around the world. So, that's going to be the lion's share of it."